In vitro efficacy of potentiated egg yolk powder against Campylobacter jejuni does not correlate with in vitro efficacy

PLoS One. 2019 Mar 7;14(3):e0212946. doi: 10.1371/journal.pone.0212946. eCollection 2019.

Abstract

Campylobacter jejuni is a zoonotic agent responsible for the foodborne gastroenteritis campylobacteriosis. Control of C. jejuni load in the poultry primary production is recognized as an avenue to reduce human exposure to the pathogen. As for now, no commercially applicable control methods exist at the farm. Several studies tested egg yolk powders, potentiated or not against C. jejuni, as feed additives for chicken and suggested that the quantity and quality of the antibodies presence in the yolk are determinant factors for the full success of this approach. Unfortunately, data from these studies inconsistently showed a reduction of cecal C. jejuni carriage. Our first goal wwas to characterize (quantification by ELISA, agglutination test, bacterial antigen recognition profiles by Western blot, bactericidal effect by serum killing assays and C. jejuni mobility by soft agar migation) the antibodies extracted from egg yolk powders originating from different egg production protocols. Secondly, these powders were microencapsulated and recharacterized. Finally the protected powders were tested as a feed additive to destabilize C. jejuni colonization in an in vivo assay. Despite the in vitro results indicating the ability of the egg yolk powders to recognize Campylobacter and potentially alter its colonization of the chicken caecum, these results were not confirmed in the in vivo trial despite that specific caecal IgY directed toward Campylobacter were detected in the groups receiving the protected powders. More research is needed on Campylobacter in order to effectively control this pathogen at the farm.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animal Feed
  • Animals
  • Antibodies, Bacterial / administration & dosage
  • Antibodies, Bacterial / immunology*
  • Antigens, Bacterial / immunology
  • Bacterial Load / drug effects
  • Campylobacter Infections / microbiology
  • Campylobacter Infections / prevention & control*
  • Campylobacter Infections / veterinary
  • Campylobacter jejuni / immunology*
  • Campylobacter jejuni / isolation & purification
  • Cecum / microbiology
  • Chickens / microbiology
  • Drug Compounding
  • Drug Evaluation, Preclinical
  • Egg Yolk / immunology*
  • Food Additives / administration & dosage*
  • Foodborne Diseases / microbiology
  • Foodborne Diseases / prevention & control
  • Immunoglobulins / administration & dosage
  • Immunoglobulins / immunology
  • Poultry Products / poisoning
  • Powders
  • Treatment Outcome

Substances

  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Food Additives
  • IgY
  • Immunoglobulins
  • Powders

Grants and funding

This work was supported by the NSERC Industrial Research Chair in Meat safety (IRCPJ/412247-2010) to AL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.